Healthcare Asia Pharma Awards
Inquire Now
Nominate Now
Download Awards Deck
Recognising Trailblazing Initiatives in the Pharmaceutical Industry
In a rapidly evolving world, where challenges are met with ingenuity, the Healthcare Asia Pharma Awards proudly shines a spotlight on those who have redefined pharmaceutical excellence.
The awards programme honors the outstanding pharma companies in Asia, those who have demonstrated unwavering commitment to innovation and excellence. Healthcare Asia is seeking the game-changers and visionaries who have redefined the pharmaceutical landscape through innovative, unique initiatives that have significantly enhanced their businesses.
✔️If your company has pushed the boundaries of innovation in the pharmaceutical realm
✔️If your initiatives have positively impacted healthcare
✔️If you believe that your company deserves the recognition for your achievements
Seize the opportunity to be honored as one of Asia's most acclaimed pharmaceutical companies. Join us as we celebrate the champions of healthcare innovation!
Awards dinner on 2025 April at Kuala Lumpur, Malaysia
TESTIMONIALS
What do our winners have to say about winning the award?
Shigeto Miyamoto Head of Digital Marketing, Bristol Myers Squibb
It's always good to get a recognition and assessment from an award-giving body and professionals such as Healthcare Asia for what we have done so far.
Shigeto Miyamoto Head of Digital Marketing, Bristol Myers Squibb
Watch videos from past winners
Healthcare Asia Pharma Awards 2024: Bushu Pharmaceuticals
Healthcare Asia Pharma Awards 2024 Winner: I.E. MEDICA, INC.
Healthcare Asia Pharma Awards 2024 Winner: MEDETHIX INCORPORATED
Photo Gallery
In the Press
Why should you enter
NETWORK
Celebrate your well-deserved award with your colleagues, clients, and peers at the Awards Dinner in Malaysia!
AMPLIFY
Reach potential clients as you let your innovations be known and honored in Asia.
EXPOSURE
Be featured in the definitive magazine for today's healthcare leaders, the Healthcare Asia with a print circulation of 5,300 copies and over 4,000 monthly unique visitors.
NEWS
MEET THE JUDGES
Abhay Bangi
Partner, Strategy & Transaction, ASEAN Healthcare Lead
EY-Parthenon
Partner, Strategy & Transaction, ASEAN Healthcare Lead
EY-Parthenon
Profile
- Abhay has over 20 years of experience in Strategy and Operations consulting
- He has advised Corporates, PEs, SWFs in identifying market attractiveness, evaluating growth and market entry options, commercial diligence, IPO readiness, strategic planning to start new business/service lines
- He is regularly seen speaking at Healthcare conferences on topics relating to innovation, disruption, and M&A in the sector
- He has also contributed to and written various articles on healthcare megatrends and commercial issues related to doing business in Asia. His articles have been featured in various industry magazines and journals
Relevant experience
- Advised a leading healthcare investment company in the region with their digital health platform strategy and implementation – including product roll out roadmap and business plan for 5 yrs
- Advised a leading Singapore based PE firm on value creation opportunities for a leading hospital chain in Vietnam, across procurement, staff productivity, asset utilization and specialty optimization
- Advised a Singapore based Healthcare operator to evaluate the sustainability and long term viability of current business strategy and to develop a growth strategy for regional expansion
- Advised a leading regional healthcare operator to optimize material spend (clinical and non-clinical) across 50+ hospitals
- Advised largest healthcare operator in Singapore on feasibility of new ventures (market and service expansion)
- Advised a leading PE fund on healthcare fund strategy covering multiple markets within Southeast Asia
- Advised the leading healthcare operator in the region to separate their labs business into an independent entity and position for future growth
- Advised an Indonesia based healthcare operator with EBITDA improvement initiatives including looking at material spend and staff/ clinician cost
Education
- Master of Business Administration (MBA), National University of Singapore
Peter Liddell
Leader for Healthcare and Life Sciences, Singapore, Leader for Life Sciences, Asia Pacific
KPMG
Leader for Healthcare and Life Sciences, Singapore, Leader for Life Sciences, Asia Pacific
KPMG
- Peter leads the Life Sciences, Health & Wellness industry sector for KPMG throughout the Asia Pacific region. He is the KPMG Singapore leader for the Healthcare & Life Sciences sector.
- Peter supports global multinational and domestic clients who are focused on the Healthcare Services, Pharmaceutical, Medical Devices and MedTech, Consumer Health and Nutritional sub-sectors. He has worked with clients within this industry sector for the past 35 years, where he has helped them to enhance their operational and financial performance.
- Peter is also the Global Operations Centre of Excellence Leader (incorporating Supply Chain, Transport & Logistics, Procurement & Advanced Manufacturing) for KPMG and is the leader of the firm's global Supply Chain executive. He is the Global Sustainable Supply Chain solution leader at KPMG where he represents the firm at external events each year, made up of presentations to external and internal stakeholders, presentations at client hosted events, presentations to client executive teams and the development and release thought leadership materials.
- Peter has designed and run large scale Transformation programs that have driven value throughout the clients' portfolios by accelerating opportunities to mitigate excessive business complexity and unnecessary operational costs, whilst helping them to position for growth and in accessing new markets. His key areas of expertise include Operational strategy; Supply chain and logistics advisory; Business process analysis, improvement and redesign; and project, change and risk management.
KPMG
Dr. Stephanie Allen
Senior Partner, Leader of Healthcare & Life-sciences Asia Pacific
Kearney
Senior Partner, Leader of Healthcare & Life-sciences Asia Pacific
Kearney
▪ Senior strategy executive with over 23 years experience in professional services; 14 years as a Partner
▪ Impressive track record of leading complex projects across global delivery teams with strategic alliance partners
▪ Skilled communicator and influencer nurturing relationships with internal and external stakeholders including policy makers and opinion
leaders
▪ Ability to decipher complexity, set a strategic direction and inspire teams to deliver critical results
▪ Knowledge of the industries that shape the Asia Pacific region and its diversity/opportunity
▪ Deep expertise in global health care
▪ Extensive experience of working with Boards, C-suite and political leaders
Dr Stephanie Allen has worked in healthcare for over 24 years. She has a deep understanding of the macro trends that are shaping the future of healthcare in a region as diverse as Asia Pacific. She understands the challenges and opportunities that the region offers in terms of access, affordability and quality but is also confident and excited that the innovation and commitment to funding and forming strategic partnerships will ensure that the region leapfrogs the rest of the world.
Chris Hardesty
Partner
Pureland Venture
Partner
Pureland Venture
Chris is a Partner at Pureland Venture, looking at early-stage healthtech value creation opportunities in the Asia Pacific and beyond. In addition, Chris serves various roles around the regional ecosystem, such as healthcare policy advising on UHC matters, executive leadership education instruction, and start-up mentorship. Mostly, Chris is excited about bringing safe, affordable medical innovations to the masses in need.
Kavita Rekhraj
Life Sciences & Health Care Industry Leader
Deloitte Asia Pacific & Southeast Asia
Life Sciences & Health Care Industry Leader
Deloitte Asia Pacific & Southeast Asia
Kavita leads the Life Sciences & Health Care sector at Deloitte Southeast Asia, and has extensive experience working with organisations in the fields of pharma, medtech, and healthtech. She actively engages with healthcare providers in planning and activating new models of care, enhancing patient experience, and driving digital transformation.
With more than 20 years of Consulting experience, Kavita’s core expertise lies in customer engagement, market entry and access, route to market, channel management, and overall business and digital transformation.
Kavita is a Chartered Financial Analyst (CFA). She holds an MSc in Actuarial Science from City University, UK, and an MA in Mathematics from the University of Cambridge.
GUIDELINES AND CRITERIA
CATEGORIES
- Most Differentiated Service of the Year
- Patient Advocacy Program of the Year
- ESG Program of the Year
- Employee Engagement of the Year
- Outcomes-based Contracting Model of the Year
- Digital Innovation of the Year
- Supply Chain Initiative of the Year
- Hospital Partnership of the Year
- Sustainability Initiative of the Year
- Packaging Design of the Year
- Marketing & Communications Initiative of the Year
- R&D Initiative of the Year
GUIDELINES
- Nomination is open to all pharmaceutical companies in the Asia Pacific region.
- Each can nominate up to 4 categories only.
- A panel of chosen experts in the healthcare and pharma industry will evaluate and rate each nomination based on the write-up and supporting documents submitted.
- Each nomination form is valid for 1 entry only. If you are nominating for several categories, please enter each entry separately.
- Deadline for the submission of entries is on 31 January 2025.
- The nomination is free of charge. Should you win, by opting for one of the winners package option, you can secure your seats at the prestigious awards dinner and gain access to a wide range of valuable benefits. To know more about the winners package pricing and entitlements, please email [email protected].
ELIGIBILITY
To be eligible for an award, the project/service/initiative must be either:
-
Launched over the last 24 calendar months
-
Launched prior to 24 calendar months but had recent innovations to improve the project/service/initiative
CRITERIA FOR JUDGING
Uniqueness and Innovation:
- Is the initiative truly unique in the market? How does the company differentiate the initiative from competitors in terms of its offerings?
- Are there examples of innovative approaches used that made the initiative successful?
Effectiveness and Impact:
- How effective are the initiatives in delivering desired objectives for the company or health outcomes to patients?
- Did the initiative meet its goals and targets? How was its success measured, and what impact did it have on your company and industry?
Dynamism:
- Can the strategy, project, service, or product easily adapt to changes and take advantage of evolving opportunities?
- How well does the company adapt to changing market dynamics and evolving customer needs?
- Does the company exhibit a capacity for innovation in response to challenges?
HOW TO ENTER?
1. Go to the online nomination form.
- Read the award entry guidelines and eligibility for your reference.
- Fill out the company information and entrant details fields.
- Choose the category you'd like to enter.
- Provide project information: Project title, 500-word summary of the entry, and client testimonial/s (if any).
2. You will then receive an email confirmation from the HCA Pharma Awards organisers after your nomination has been received.
3. To substantiate your entry, send supporting documents or photos to [email protected].
- Supporting documents and photos must be in PDF, PowerPoint and/or JPG format
- For supporting videos, Youtube.com or Vimeo.com links must be provided.
KEY DATES
Deadline for submission: 31 January 2025, Friday
Awards presentation: April 2025
Past Winners
Alcon
- Marketing & Communications Initiative of the Year - India
- Digital Innovation of the Year - Singapore
- Marketing & Communications Initiative of the Year - Singapore
- ESG Program of the Year - Japan
- Sustainability Initiative of the Year - Japan
Cipla Ltd.
- Patient Advocacy Program of the Year - India
- Supply Chain Initiative of the Year - Philippines
- Hospital Partnership of the Year - Philippines
- Most Differentiated Service of the Year - Philippines
Metrochem Pvt Limited
- Sustainability Initiative of the Year - India
- Supply Chain Initiative of the Year - India
- Marketing & Communications Initiative of the Year - Australia
- Patient Advocacy Program of the Year - Singapore
Takeda Pharmaceuticals International AG Singapore Branch
- Healthcare Access Innovation of the Year - Singapore
- Marketing & Communications Initiative of the Year - Thailand
Takeda Pharmaceuticals Taiwan, Ltd
- Patient Advocacy Program of the Year - Taiwan
ZP Therapeutics
Most Differentiated Service of the Year - Singapore
- Patient Advocacy Program of the Year - Thailand
Novo Nordisk Pharma (Taiwan) Ltd.
- ESG Program of the Year - Taiwan
- Marketing & Communications Initiative of the Year - India
Dr Reddy’s Laboratories
- Marketing & Communications Initiative of the Year - India
- Most Differentiated Service of the Year - Singapore
- Outcomes-based Contracting Model of the Year - Singapore
- Patient Advocacy Program of the Year - Japan
- Digital Innovation of the Year - Japan
Diaceutics Pte Digital
- Innovation of the Year - Singapore
Abbott Healthcare Pvt. Ltd
- Hospital Partnership of the Year - India
- Marketing & Communications Initiative of the Year - Japan
Cipla Limited
- Marketing & Communications Initiative of the Year - India
HIMONT PHARMACEUTICALS
- Packaging Design of the Year - Pakistan
Takeda Pharmaceutical Company Limited
- Digital Innovation of the Year - Japan
- Most Differentiated Service of the Year - Japan
Cipla Ltd.
- Marketing & Communications Initiative of the Year - India
Glenmark Philippines Inc
- Marketing & Communications Initiative of the Year - Philippines
Merck Sharp & Dohme (I.A.) LLC
- Digital Innovation of the Year - Philippines
- Patient Advocacy Program of the Year - Philippines
Oliver Healthcare Packaging
- Packaging Design of the Year - Singapore
Pfizer Pakistan Ltd
- Corporate Social Responsibility Program of the Year - Pakistan
- Marketing & Communications Initiative of the Year - Pakistan
CONTACT US
For more details, contact:
Julie Anne Nunez
(+65) 3158 1386 ext. 221
MEET THE JUDGES
Abhay Bangi
Partner, Strategy & Transaction, ASEAN Healthcare Lead
EY-Parthenon
Partner, Strategy & Transaction, ASEAN Healthcare Lead
EY-Parthenon
Profile
- Abhay has over 20 years of experience in Strategy and Operations consulting
- He has advised Corporates, PEs, SWFs in identifying market attractiveness, evaluating growth and market entry options, commercial diligence, IPO readiness, strategic planning to start new business/service lines
- He is regularly seen speaking at Healthcare conferences on topics relating to innovation, disruption, and M&A in the sector
- He has also contributed to and written various articles on healthcare megatrends and commercial issues related to doing business in Asia. His articles have been featured in various industry magazines and journals
Relevant experience
- Advised a leading healthcare investment company in the region with their digital health platform strategy and implementation – including product roll out roadmap and business plan for 5 yrs
- Advised a leading Singapore based PE firm on value creation opportunities for a leading hospital chain in Vietnam, across procurement, staff productivity, asset utilization and specialty optimization
- Advised a Singapore based Healthcare operator to evaluate the sustainability and long term viability of current business strategy and to develop a growth strategy for regional expansion
- Advised a leading regional healthcare operator to optimize material spend (clinical and non-clinical) across 50+ hospitals
- Advised largest healthcare operator in Singapore on feasibility of new ventures (market and service expansion)
- Advised a leading PE fund on healthcare fund strategy covering multiple markets within Southeast Asia
- Advised the leading healthcare operator in the region to separate their labs business into an independent entity and position for future growth
- Advised an Indonesia based healthcare operator with EBITDA improvement initiatives including looking at material spend and staff/ clinician cost
Education
- Master of Business Administration (MBA), National University of Singapore
Peter Liddell
Leader for Healthcare and Life Sciences, Singapore, Leader for Life Sciences, Asia Pacific
KPMG
Leader for Healthcare and Life Sciences, Singapore, Leader for Life Sciences, Asia Pacific
KPMG
- Peter leads the Life Sciences, Health & Wellness industry sector for KPMG throughout the Asia Pacific region. He is the KPMG Singapore leader for the Healthcare & Life Sciences sector.
- Peter supports global multinational and domestic clients who are focused on the Healthcare Services, Pharmaceutical, Medical Devices and MedTech, Consumer Health and Nutritional sub-sectors. He has worked with clients within this industry sector for the past 35 years, where he has helped them to enhance their operational and financial performance.
- Peter is also the Global Operations Centre of Excellence Leader (incorporating Supply Chain, Transport & Logistics, Procurement & Advanced Manufacturing) for KPMG and is the leader of the firm's global Supply Chain executive. He is the Global Sustainable Supply Chain solution leader at KPMG where he represents the firm at external events each year, made up of presentations to external and internal stakeholders, presentations at client hosted events, presentations to client executive teams and the development and release thought leadership materials.
- Peter has designed and run large scale Transformation programs that have driven value throughout the clients' portfolios by accelerating opportunities to mitigate excessive business complexity and unnecessary operational costs, whilst helping them to position for growth and in accessing new markets. His key areas of expertise include Operational strategy; Supply chain and logistics advisory; Business process analysis, improvement and redesign; and project, change and risk management.
KPMG
Dr. Stephanie Allen
Senior Partner, Leader of Healthcare & Life-sciences Asia Pacific
Kearney
Senior Partner, Leader of Healthcare & Life-sciences Asia Pacific
Kearney
▪ Senior strategy executive with over 23 years experience in professional services; 14 years as a Partner
▪ Impressive track record of leading complex projects across global delivery teams with strategic alliance partners
▪ Skilled communicator and influencer nurturing relationships with internal and external stakeholders including policy makers and opinion
leaders
▪ Ability to decipher complexity, set a strategic direction and inspire teams to deliver critical results
▪ Knowledge of the industries that shape the Asia Pacific region and its diversity/opportunity
▪ Deep expertise in global health care
▪ Extensive experience of working with Boards, C-suite and political leaders
Dr Stephanie Allen has worked in healthcare for over 24 years. She has a deep understanding of the macro trends that are shaping the future of healthcare in a region as diverse as Asia Pacific. She understands the challenges and opportunities that the region offers in terms of access, affordability and quality but is also confident and excited that the innovation and commitment to funding and forming strategic partnerships will ensure that the region leapfrogs the rest of the world.
Chris Hardesty
Partner
Pureland Venture
Partner
Pureland Venture
Chris is a Partner at Pureland Venture, looking at early-stage healthtech value creation opportunities in the Asia Pacific and beyond. In addition, Chris serves various roles around the regional ecosystem, such as healthcare policy advising on UHC matters, executive leadership education instruction, and start-up mentorship. Mostly, Chris is excited about bringing safe, affordable medical innovations to the masses in need.
Kavita Rekhraj
Life Sciences & Health Care Industry Leader
Deloitte Asia Pacific & Southeast Asia
Life Sciences & Health Care Industry Leader
Deloitte Asia Pacific & Southeast Asia
Kavita leads the Life Sciences & Health Care sector at Deloitte Southeast Asia, and has extensive experience working with organisations in the fields of pharma, medtech, and healthtech. She actively engages with healthcare providers in planning and activating new models of care, enhancing patient experience, and driving digital transformation.
With more than 20 years of Consulting experience, Kavita’s core expertise lies in customer engagement, market entry and access, route to market, channel management, and overall business and digital transformation.
Kavita is a Chartered Financial Analyst (CFA). She holds an MSc in Actuarial Science from City University, UK, and an MA in Mathematics from the University of Cambridge.
Healthcare Asia Awards 2024 Event Highlights
TESTIMONIALS
Healthcare Asia Pharma Awards 2024: Bushu Pharmaceuticals
Healthcare Asia Pharma Awards 2024 Winner: I.E. MEDICA, INC.
Healthcare Asia Pharma Awards 2024 Winner: MEDETHIX INCORPORATED
Healthcare Asia Pharma Awards 2023 Winner: Celltrion Healthcare Thailand
Healthcare Asia Pharma Awards 2023 Winner: Novo Nordisk Pharma (Taiwan) Ltd.
Healthcare Asia Pharma Awards 2023 Winner: Scientimed Solutions Pvt Ltd & Dr Reddy’s Laboratories
Shigeto Miyamoto,Head of Digital Marketing, Bristol-Myers Squibb
Mayumi Kaneda, Amgen KK
Shigeto Miyamoto, Head of Digital Marketing, Bristol Myers Squibb
Dr. Beaver Tamesis, President and Managing Director of MSD Philippines
Awards Highlights
Recent News
Recent News
KPMG’s Peter Liddell advocates resilient healthcare solutions
He discussed the pressing challenges and transformative solutions shaping the future of healthcare in the Asia Pacific.
The healthcare industry in Asia Pacific is fundamentally evolving but faced with challenges. To stay resilient...
Highlight your innovative medical initiatives at Healthcare Asia Awards, Medtech Awards, Pharma Awards 2025
The awards programmes honour outstanding leaders and companies in the healthcare industry across Asia.
The healthcare industry in Asia is currently faced with endless opportunities for innovation and progress. With this, it is...
MSD navigates the pandemic tapestry in COVID-19 fight
It has navigated the complexities of the challenging period through a proactive approach.
In the turbulent landscape of the COVID-19 pandemic, pharmaceutical company MSD's unwavering commitment to patients has set an...
ZP Therapeutics bagged Healthcare Asia Pharma Awards 2024 for continuing medical education
It has engaged global medical experts and opinion makers to set up medical education events.
ZP Therapeutics, a division of Zuellig Pharma, brought home the Most Differentiated Service of the Year - Singapore category win at the...
Takeda Pharmaceuticals Taiwan lauded for Innovative Cancer Care Awareness Campaign with Advocacy Partner, HOPE Foundation for Cancer Care
The company was awarded the Patient Advocacy Program of the Year accolade.
Takeda Pharmaceuticals Taiwan took home the Patient Advocacy Program of the Year award for its successful “Taiwan 555 Challenge”, which aimed to advance...
Takeda Pharmaceutical’s Thailand dengue awareness campaign paves the way for future public health communication
The company’s ING-MA campaign wins Marketing & Communications Initiative of the Year - Thailand at the Healthcare Asia Pharma Awards.
Thailand faces a significant public health challenge: dengue. With over 1.2 million cases...
Takeda Pharmaceuticals secures Healthcare Asia Pharma Awards for Patient Assistance Programme
The affordability-based programme is designed to be equitable and sustainable.
Multinational pharmaceutical company Takeda Pharmaceuticals International AG Singapore Branch clinched the Healthcare Access Innovation of the Year...
Bushu Pharmaceuticals brings home two wins at Healthcare Asia Pharma Awards 2024
It has initiated CO2 emission reduction and wastewater management initiatives to support the environment and the industry.
Japanese CDMO company Bushu Pharmaceuticals clinched two major titles at the recently held Healthcare...
FREQUENTLY ASKED QUESTIONS
What can I nominate?
You may nominate:
✓ Unique and innovative initiatives that made a positive impact your company's business, growth, and/or overall performance
✓ Best practices and strategies that helped your team to be successful
✓ Pioneering technologies and digital transformation journey of your company
✓ Your company’s overall success, performance and growth
✓ Any achievement that you think is deserving of a prestigious award
How do I nominate?
- Go to the online nomination form and read the nomination guidelines.
- Fill in the required details about the company and contact person for the nomination.
- Select your category.
- Provide your project title, 500-word write-up, client feedback (if any), key achievements, and photos of the project that you are nominating.
- Choose your winners package
- Wait for the nomination confirmation email and acknowledge it once received.
Note:
-
Photos are required while supporting documents are optional but will highly increase the chances of winning.
Can I nominate for more than 1 category?
Yes, each company can nominate for a maximum of 4 categories.
Can I send two or more entries for one category?
Yes, you can nominate for a maximum of two entries for a category. If you are nominating several projects, please enter each entry separately.
How many winners per category?
There will only be one winner per category on each country ie. "ESG Program of the Year - Singapore", "ESG Program of the Year - Hong Kong", etc.
Is there a cost to nominate?
The nomination is free of charge. Should you win, by opting for one of the winners package option, you can secure your seats at the prestigious awards dinner and gain access to a wide range of valuable benefits. To know more about the winners package entitlements and pricing, please email [email protected]
Will there be an awards dinner this year?
Yes, Healthcare Asia will organise an Awards Dinner that will be held in Kuala Lumpur, Malaysia. Details will be communicated to the winners accordingly upon announcement of results.
What is Healthcare Asia?
Healthcare Asia is the industry magazine serving Asia’s hospital owners, investors, administrators and policy makers. There are many magazines for clinical practitioners in medicine and healthcare, but Healthcare Asia focuses on the running of healthcare organisations, both public and private, and discusses the policy issues that govern healthcare in the Asian region.